延迟治疗对老年头颈癌患者住院的影响:一项多中心研究
这项回顾性多中心研究纳入2015至2017年间两家三级转诊中心新诊断的525例≥60岁头颈癌患者,评估治疗启动延迟对住院、总生存和复发的影响。中位治疗等待时间为34.0天,36.3%的患者在30天内开始治疗。调整模型显示,治疗等待间隔≥30天是治疗后第一年住院超过14天的显著预测因素(比值比4.66,95%CI 2.59-8.37,P<.001),但延迟与总生存或肿瘤复发无关。
要点
- 525例老年头颈癌患者中位治疗等待时间34.0天,36.3%在30天内开始治疗。
- 治疗等待≥30天预测第一年住院超过14天,比值比4.66(95%CI 2.59-8.37,P<.001)。
- 治疗延迟与总生存或肿瘤复发无显著关联。
核心结论
- 治疗延迟是老年头颈癌患者住院的独立预测因素,确保及时启动治疗需要结构良好、快速通道式的诊疗路径。
研究设计与样本
- 回顾性多中心研究,纳入两家三级转诊中心2015至2017年间新诊断的≥60岁头颈癌患者,共525例,平均年龄70.7岁,男性占70.7%。
主要发现
- 中位治疗等待时间为34.0天,36.3%的患者在30天内开始治疗,两中心间差异P=.576。
- 放疗患者的治疗等待时间长于手术患者(39.0天 vs 29.0天,P<.001)。
- 多变量分析中,当前吸烟状态、IV期肿瘤和根治性放疗与治疗延迟显著相关。
- 调整模型中,治疗等待间隔≥30天是治疗后第一年住院超过14天的显著预测因素(比值比4.66,95%CI 2.59-8.37,P<.001)。
- 治疗延迟与总生存或肿瘤复发无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the impact of delay in treatment initiation on hospitalization, overall survival, and recurrence in older patients with head and neck cancer (HNC). STUDY DESIGN: Retrospective multicenter study. SETTING: Two tertiary referral centers. METHODS: All patients with newly diagnosed HNC (≥60 years) treated between 2015 and 2017 were retrospectively included. Time-to-treatment intervals were assessed (ie, calendar days between first visit and start of treatment). Multiple multivariable models were performed with hospital admission days (>14 days), survival, and recurrence as dependent outcome variables. RESULTS: In total, 525 patients were enrolled. The mean age was 70.7 years and 70.7% were male. Median time to treatment was 34.0 days, and 36.3% started treatment within 30 days (P = .576 between centers). Patients with radiotherapy had longer time to treatment than surgical patients (39.0 vs 29.0 days, P < .001). Current smoking status, stage IV tumors, and definitive radiotherapy were significantly associated with delay in the multivariable analysis. Time-to-treatment interval ≥30 days was a significant predictor of longer hospital admission (>14 days) in the first year after treatment in an adjusted model (odds ratio, 4.66 [95% CI, 2.59-8.37]; P < .001). Delay in treatment initiation was not associated with overall survival or tumor recurrence. CONCLUSION: This study highlights the importance and challenges of ensuring timely treatment initiation in older patients with HNC, as treatment delay was an independent predictor of hospitalization. During oncologic workup, taking time to consider patient-centered outcomes (including minimizing time spent in hospital) while ensuring timely start of treatment requires well-structured, fast-track care pathways.
引用
- Schoonbeek RC, Festen S, Rashid R, et al. Impact of Delay on Hospitalization in Older Patients With Head and Neck Cancer: A Multicenter Study. Otolaryngol Head Neck Surg. 2022. PMID: 35043734. doi:10.1177/01945998211072828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。